Medtronic to Acquire Scientia Vascular in $550M Stroke-Care Deal

Dublin, Ireland, March 10, 2026 (Reuters) -- Medtronic announced plans to acquire Scientia Vascular for approximately $550 million, expanding its portfolio of devices used to treat stroke. The Salt Lake City–based company develops specialized guidewires and catheters designed to navigate delicate blood vessels in the brain, technologies that will integrate with Medtronic’s existing neurovascular product line. The transaction, expected to close in the first half of fiscal 2027, supports Medtronic’s strategy to drive growth through targeted acquisitions while strengthening its capabilities in treating both hemorrhagic and ischemic stroke.

Read full article here.